Literature DB >> 19542750

Somatotropin adenoma and resistance to thyroid hormone.

D Berker1, Y Aydin, Y A Tutuncu, S Isik, T Delibasi, M Berker, S Guler, N Kamel.   

Abstract

Resistance to thyroid hormone (RTH) is a rare disease characterized by non-suppressed TSH in spite of high free thyroid hormone levels. Up to date, in the literature, there are more than 600 RTH cases, but co-incidental hypophyseal adenoma was reported in only 1 case. In the literature, despite reported cases with thyrotropinoma accompanying RTH, we could not find a case with somatotropinoma accompanying RTH. Here, we report a 34-yr-old male patient, who was admitted to the hospital with complaints of dyspnea, chest pain, and palpitation in 2003. His alpha- subunit value was normal and the alpha-subunit/TSH molar ratio was <1. His response to TRH stimulation test was normal. His TSH level was suppressed in the T3 suppression test. Hypophyseal magnetic resonance imaging showed a 6-mm hypophyseal microadenoma. Levels of all anterior hypophyseal hormones, including GH and IGF-I, were normal. Oral glucose tolerance test (OGTT)-GH suppression test was normal. The patient was followed with the diagnosis of RTH and incidental hypophyseal adenoma. After 3 yr, because of high levels of IGF-I: 901 ng/ml (68-324), the OGTT-GH suppression test was reported and no suppression was detected. Thus, the patient was referred to surgery with the pre-diagnosis of RTH and acromegaly. Immunohistochemistry was showed as strong GH staining with low Ki 67 index while TSH and other anterior hypophyseal hormones stainings were negative. Post-operative thyroid hormones were still high.

Entities:  

Mesh:

Year:  2009        PMID: 19542750     DOI: 10.1007/BF03346468

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor.

Authors:  S Ando; N J Sarlis; E H Oldfield; P M Yen
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

2.  A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma.

Authors:  J D Safer; S D Colan; L M Fraser; F E Wondisford
Journal:  Thyroid       Date:  2001-03       Impact factor: 6.568

3.  Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation.

Authors:  M Karl; S W Lamberts; J W Koper; D A Katz; N E Huizenga; T Kino; B R Haddad; M R Hughes; G P Chrousos
Journal:  Proc Assoc Am Physicians       Date:  1996-07

4.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone.

Authors:  S Refetoff; L T DeWind; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

Review 5.  Resistance to thyroid hormone: an historical overview.

Authors:  S Refetoff
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

6.  Clinically silent somatotropinomas may be biochemically active.

Authors:  Alla A Sakharova; Eleni V Dimaraki; William F Chandler; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2005-01-25       Impact factor: 5.958

Review 7.  Thyroid hormone resistance.

Authors:  Tolulope O Olateju; Mark P J Vanderpump
Journal:  Ann Clin Biochem       Date:  2006-11       Impact factor: 2.057

8.  Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.

Authors:  Eleni V Dimaraki; Craig A Jaffe; Roberta DeMott-Friberg; William F Chandler; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

9.  Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone.

Authors:  K Watanabe; T Kameya; A Yamauchi; N Yamamoto; A Kuwayama; I Takei; H Maruyama; T Saruta
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

10.  Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.

Authors:  P Beck-Peccoz; R Roncoroni; S Mariotti; G Medri; C Marcocci; G Brabant; F Forloni; A Pinchera; G Faglia
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

View more
  1 in total

1.  A case of resistance to thyroid hormone with thyroid cancer.

Authors:  Hee Kyung Kim; Doi Kim; Eun Hyung Yoo; Ji In Lee; Hye Won Jang; Alice Hyun Kyung Tan; Kyu Yeon Hur; Jae Hyeon Kim; Kwang-Won Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  J Korean Med Sci       Date:  2010-08-12       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.